On August 20, Dian Diagnostics Group Co.,Ltd. released its semi-annual report.
According to the announcement, the company recorded operating revenue of 4,936,484,994.33 yuan for the first half of the year, representing a year-over-year decrease of 20.61%. Net profit attributable to shareholders of the listed company totaled 10,277,234.44 yuan, marking a significant decline of 85.68% compared to the same period last year.
The announcement also revealed that among the company's top ten circulating shareholders, Bank of China Co., Ltd. - China Merchants Advantage Enterprise Flexible Allocation Hybrid Securities Investment Fund has emerged as a new circulating shareholder.
Comments